Assessment of Tele-expertise for Second Medical Opinion on Pathological Diagnosis
1 other identifier
observational
470
1 country
11
Brief Summary
The purpose of this study is to determine whether digitalizing pathological slides and let it accessible on a server for a second medical opinion (tele-expertise) would reduce the time to diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2013
Typical duration for all trials
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 5, 2015
CompletedFirst Posted
Study publicly available on registry
March 2, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedDecember 9, 2015
June 1, 2015
1.7 years
February 5, 2015
December 8, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Delay of second medical opinion
Between preparation of the slide and the result
Up to 10 weeks
Secondary Outcomes (3)
Number of second medical opinion requested
During the whole study (around 8 months)
Overall costs
Within 6 months after the start of tele-expertise
Number of times that the pathologist who gave the second opinion required the original material
During the whole study (around 8 months)
Study Arms (2)
Before tele-expertise
Usual second opinion with pathological slides sent by mailing
During Tele-expertise
Second opinion with tele-expertise
Interventions
Eligibility Criteria
Patients in need for a second medical opinion on a pathological sample
You may qualify if:
- All patients in need for a second medical opinion on a pathological sample
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
Hôpital Saint Antoine
Paris, Paris, 75012, France
Centre de Pathologie- Bièvres
Bièvres, France
Hôpital Henri Mondor
Créteil, France
Centre Hospitalier Simone Veil
Eaubonne, France
Hôpital Bicêtre
Le Kremlin-Bicêtre, 94270, France
Hôpital Bichat
Paris, France
Hôpital Cochin
Paris, France
Hôpital Saint Louis
Paris, France
Centre Hospitalier René Dubos
Pontoise, 95303, France
Hôpital Paul Brousse
Villejuif, France
Centre Hospitalier de Villeneuve Saint Georges
Villeneuve-Saint-Georges, France
Related Publications (2)
Kidholm K, Ekeland AG, Jensen LK, Rasmussen J, Pedersen CD, Bowes A, Flottorp SA, Bech M. A model for assessment of telemedicine applications: mast. Int J Technol Assess Health Care. 2012 Jan;28(1):44-51. doi: 10.1017/S0266462311000638.
PMID: 22617736BACKGROUNDCharrier N, Zarca K, Durand-Zaleski I, Calinaud C; ARS Ile de France telemedicine group. Efficacy and cost effectiveness of telemedicine for improving access to care in the Paris region: study protocols for eight trials. BMC Health Serv Res. 2016 Feb 8;16:45. doi: 10.1186/s12913-016-1281-1.
PMID: 26857558DERIVED
Related Links
Biospecimen
Fixed tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Catherine Guettier, MD, PhD
Hôpital Bicêtre. Assistance Publique - Hôpitaux de Paris
- PRINCIPAL INVESTIGATOR
Isabelle Durand-Zaleski, MD, PhD
DRCD URC Eco. Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2015
First Posted
March 2, 2015
Study Start
September 1, 2013
Primary Completion
June 1, 2015
Study Completion
October 1, 2015
Last Updated
December 9, 2015
Record last verified: 2015-06